GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » 12-1 Month Momentum %

Bharat Immunologicals & Biologicals (BOM:524663) 12-1 Month Momentum % : 29.98% (As of Jun. 09, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-09), Bharat Immunologicals & Biologicals's 12-1 Month Momentum % is 29.98%.

The industry rank for Bharat Immunologicals & Biologicals's 12-1 Month Momentum % or its related term are showing as below:

BOM:524663's 12-1 Month Momentum % is ranked better than
81.8% of 1478 companies
in the Biotechnology industry
Industry Median: -22.7 vs BOM:524663: 29.98

Competitive Comparison of Bharat Immunologicals & Biologicals's 12-1 Month Momentum %

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's 12-1 Month Momentum % falls into.



Bharat Immunologicals & Biologicals  (BOM:524663) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bharat Immunologicals & Biologicals  (BOM:524663) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Bharat Immunologicals & Biologicals 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines